Polycystic kidney disease

Request an Appointment
Print

Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.

Departments that treat this condition

Doctors who treat this condition

Edit search filters
close

Narrow your search

  1. There are no doctors whose last name begins with the letter A
  2. Find a doctor whose last name begins with the letter B
  3. Find a doctor whose last name begins with the letter C
  4. Find a doctor whose last name begins with the letter D
  5. There are no doctors whose last name begins with the letter E
  6. There are no doctors whose last name begins with the letter F
  7. Find a doctor whose last name begins with the letter G
  8. Find a doctor whose last name begins with the letter H
  9. There are no doctors whose last name begins with the letter I
  10. Find a doctor whose last name begins with the letter J
  11. Find a doctor whose last name begins with the letter K
  12. Find a doctor whose last name begins with the letter L
  13. Find a doctor whose last name begins with the letter M
  14. There are no doctors whose last name begins with the letter N
  15. Find a doctor whose last name begins with the letter O
  16. Find a doctor whose last name begins with the letter P
  17. There are no doctors whose last name begins with the letter Q
  18. There are no doctors whose last name begins with the letter R
  19. Find a doctor whose last name begins with the letter S
  20. Find a doctor whose last name begins with the letter T
  21. There are no doctors whose last name begins with the letter U
  22. There are no doctors whose last name begins with the letter V
  23. Find a doctor whose last name begins with the letter W
  24. There are no doctors whose last name begins with the letter X
  25. There are no doctors whose last name begins with the letter Y
  26. Find a doctor whose last name begins with the letter Z
Reset all filters

Displaying 1-10 out of 23 doctors available

  1. Andrew J. Bentall, M.B., Ch.B., M.D.

    Andrew J. Bentall, M.B., Ch.B., M.D.

    1. Transplant Nephrologist
    2. Nephrologist
    1. Rochester, MN
    Areas of focus:

    Living donor kidney transplant, Kidney transplant, Living-donor transplant, Pancreas transplant, Transplant, Simultaneo...us pancreas-kidney transplant, Preemptive kidney transplant, Immunosuppressive drug therapy, Pre-transplant evaluation, Post-transplant long-term care, Living kidney donation, Pre-kidney transplant evaluation, Kidney donor evaluation, Preventing infection in immunocompromised patient, Preoperative cardiac evaluation, Paired kidney donation, Post-pancreas transplant care, Living organ donation, Post-kidney transplant care, Pre-pancreas transplant evaluation, Polycystic kidney disease, Hydronephrosis, Kidney infection, Diabetic nephropathy, Hyperparathyroidism, Thin basement membrane disease, Metabolic acidosis, Chronic kidney disease, Renal cell carcinoma, End-stage renal disease, Inherited cystic kidney disorder, Glomerulonephritis, Nephrotic syndrome, Renal parenchymal disease, Simple kidney cyst, IgA nephropathy, Acute kidney inury, Hyperoxaluria, Lupus nephritis, Secondary high blood pressure, Minimal change disease, Renovascular disease, Immunotactoid glomerulonephritis, Hereditary nephritis, Secondary hyperparathyroidism, Post-transplant hypertension, Tertiary hyperparathyroidism, Malignant hypertension, Membranoproliferative glomerulonephritis, Interstitial nephritis, Metabolic kidney disease, Kidney failure, Hypertensive nephropathy, Renal amyloidosis, Renal tubular acidosis, Myeloma kidney disease, Hyperphosphatemia, Primary hyperoxaluria, Renal papillary necrosis, Renovascular hypertension

  2. Fouad T. Chebib, M.D.

    Fouad T. Chebib, M.D.

    1. Nephrologist
    1. Jacksonville, FL
    Areas of focus:

    Kidney transplant, Kidney dialysis, Polycystic kidney disease, End-stage renal disease, Kidney cyst, Cystic disorders, ...Polycystic liver disease, Kidney failure, Autosomal recessive polycystic kidney disease

  3. Alex Cortez, M.D.

    Alex Cortez, M.D.

    1. Transplant Surgeon
    1. Rochester, MN
    Areas of focus:

    Liver transplant, Kidney transplant, Cholecystectomy, Liver resection, Hernia repair, Liver cyst fenestration, Cholangi...ocarcinoma, Primary sclerosing cholangitis, Polycystic kidney disease, Hepatocellular carcinoma, Primary biliary cholangitis, Cirrhosis, Acute liver failure, Autoimmune hepatitis, Liver cancer, End-stage renal disease, Alcoholic liver disease, Portal hypertension, Chronic liver disease, Budd-Chiari syndrome, Metabolic liver disease, Polycystic liver disease

  4. Carl H. Cramer, II, M.D.

    Carl H. Cramer, II, M.D.

    1. Transplant Nephrologist
    2. Pediatrician
    3. Pediatric Nephrologist
    1. Rochester, MN
    Areas of focus:

    Kidney transplant, Hemodialysis, Peritoneal dialysis, Dialysis, High blood pressure, Polycystic kidney disease, Hydrone...phrosis, Kidney infection, Blood in urine, Urinary tract infection, Thin basement membrane disease, Chronic kidney disease, End-stage renal disease, Glomerulonephritis, Nephrotic syndrome, High blood pressure in children, Renal artery stenosis, IgA nephropathy, Kidney cyst, Acute kidney inury, Tuberous sclerosis, Focal segmental glomerulosclerosis, Lupus nephritis, Secondary high blood pressure, Medullary sponge kidney, Nail disease, Minimal change disease, Renovascular disease, Nephritis, Hereditary nephritis, Protein in urine, Bardet-Biedl syndrome, Post-transplant hypertension, Malignant hypertension, Single kidney, Childhood nephrotic syndrome, Membranoproliferative glomerulonephritis, Interstitial nephritis, Kidney failure, Shrinking kidney, Renal tubular acidosis, Kidney injury, Multicystic kidney dysplasia, Postural proteinuria, Horseshoe kidney, Kidney angiomyolipoma, Renovascular hypertension, Glomerular disease, Congenital kidney disorder

  5. Neera K. Dahl, M.D., Ph.D.

    Neera K. Dahl, M.D., Ph.D.

    1. Internist
    2. Nephrologist
    1. Rochester, MN
    Areas of focus:

    Kidney stone, Polycystic kidney disease, Genetic disorder, Polycystic liver disease

  6. Navin R. Gupta, M.D.

    Navin R. Gupta, M.D.

    1. Internist
    2. Nephrologist
    1. Rochester, MN
    Areas of focus:

    High blood pressure, Kidney stone, Polycystic kidney disease, Chronic kidney disease, Acute kidney inury, Focal segment...al glomerulosclerosis, Alport syndrome

  7. Christian Hanna, M.D., M.S.

    Christian Hanna, M.D., M.S.

    1. Pediatric Nephrologist
    Areas of focus:

    Kidney transplant, Hemodialysis, Peritoneal dialysis, Dialysis, Continuous renal replacement therapy, Kidney stone, Pol...ycystic kidney disease, Hydronephrosis, Hemolytic uremic syndrome, Kidney infection, Blood in urine, Urinary tract infection, Chronic kidney disease, End-stage renal disease, Membranous nephropathy, Inherited cystic kidney disorder, Nephrotic syndrome, High blood pressure in children, Renal artery stenosis, IgA nephropathy, Kidney cyst, Acute kidney inury, Focal segmental glomerulosclerosis, Medullary sponge kidney, Minimal change disease, Renovascular disease, Protein in urine, Single kidney, Childhood nephrotic syndrome, Membranoproliferative glomerulonephritis, Renal tubular acidosis, Multicystic kidney dysplasia, Postural proteinuria, Horseshoe kidney, Glomerular disease, Congenital kidney disorder

  8. Marie C. Hogan, M.D., Ph.D.

    Marie C. Hogan, M.D., Ph.D.

    1. Internist
    2. Nephrologist
    1. Rochester, MN
    Areas of focus:

    Polycystic kidney disease, End-stage renal disease, IgA nephropathy, Focal segmental glomerulosclerosis, Glomerular dis...ease

  9. Musab S. Hommos, M.B.B.S.

    Musab S. Hommos, M.B.B.S.

    1. Nephrologist
    1. Phoenix, AZ
    Areas of focus:

    High blood pressure, Polycystic kidney disease, Amyloidosis, Chronic kidney disease, End-stage renal disease, Glomerulo...nephritis, Renal artery stenosis, Acute kidney inury, Aldosteronoma

  10. Tambi Jarmi, M.D.

    Tambi Jarmi, M.D.

    1. Transplant Nephrologist
    1. Jacksonville, FL
    Areas of focus:

    Kidney transplant, Pancreas transplant, Immunosuppressive drug therapy, Pre-transplant evaluation, Post-transplant long...-term care, Polycystic kidney disease, Diabetic nephropathy, Chronic kidney disease, End-stage renal disease, Acute kidney inury

Research

Mayo Clinic is a leader in polycystic kidney disease research. Mayo Clinic researchers discovered:

  • The main gene that causes autosomal dominant polycystic kidney disease (ADPKD).
  • The gene that causes autosomal recessive polycystic kidney disease (ARPKD).
  • A gene that causes a rare form of polycystic kidney disease associated with multiple malformations (Meckel-Gruber syndrome).
  • The polycystic kidney disease proteins polycystin 1, polycystin 2 and fibrocystin.
  • The polycystic kidney and liver disease gene GANAB.
  • Other genes that cause kidney cyst disease, such as DNAJB11.
  • A way to use CT and MRI scans to classify polycystic kidney disease and select people for clinical trials of new therapies.
  • A pioneering approach to surgery to remove diseased kidneys and transplant healthy kidneys during the same surgery.

Lab-based research at Mayo Clinic has focused on:

  • Explaining how mutations in the polycystic kidney disease genes lead to cyst development.
  • Preclinical studies in drug therapies for polycystic kidney disease, such as octreotide and vasopressin antagonists.
  • Finding effective therapies for polycystic kidney disease and liver disease.
  • Improving imaging assessments of polycystic kidney disease and liver disease.
  • Studies of polycystic kidney disease proteins in urine particles known as exosomes.
  • Testing new compounds in animal models of polycystic kidney disease.
  • Studies of the hairlike structures (primary cilia) implicated in polycystic kidney disease.

Mayo Clinic research has shown that a medicine called tolvaptan can slow the development and progression of polycystic kidney disease in animal models.

Mayo Clinic researchers also have shown that another medicine called octreotide delays the development of both polycystic kidney disease and polycystic liver disease and is a potential treatment option for people who have PKD with liver involvement.

These medicines are now in clinical trials, and tolvaptan is approved for use in some countries for polycystic kidney disease. In addition, nephrologists at Mayo Clinic are working to understand how to prevent the progression of kidney (renal) disease in patients with polycystic kidney disease.

Read more about the extensive research being done at Mayo Clinic's Robert M. and Billie Kelley Pirnie Translational Polycystic Kidney Disease (PKD) Center.

The Mayo Nephrology Collaborative Group — a consortium of nephrologists across the United States — develops and conducts studies aimed at improving treatment of patients with renal diseases, including polycystic kidney disease.

Polycystic Kidney Disease Resource Center

Publications

See a list of publications about polycystic kidney disease by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

Research Profiles

Edit search filters
close

Narrow your search

View all physicians • Arizona

By Mayo Clinic Staff

Polycystic kidney disease care at Mayo Clinic

Request an appointment
Diagnosis & treatmentCare at Mayo Clinic
Aug. 26, 2025
Print

Living with polycystic kidney disease?

Connect with others like you for support and answers to your questions in the Transplants support group on Mayo Clinic Connect, a patient community.

Transplants Discussions

See more discussions

Related

Associated Procedures

News from Mayo Clinic

Products & Services

Polycystic kidney disease

Research: It's all about patients

[MUSIC PLAYING]

Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to advance how we can best help the patient, how to make sure the patient comes first in care. So in many ways, it's a cycle. It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes right — and let's say it's helpful or beneficial — then brought on as a standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to put it in its own spotlight.